Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Journal of Animal Science|August 2, 2012
Parentage verification in field progeny testing program of Mehsana buffaloS J Jakhesara, D N Rank, J D Kansara, et al.
Future Oncology (London, England)|January 27, 2025
Real-world treatment patterns and health outcomes for patients with myelofibrosis treated with fedratinibFrancesco Passamonti, Siddhi Korgaonkar, Rohan C Parikh, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 1, 2025
Healthcare Resource Utilization and Cost Comparison Between Palbociclib, Abemaciclib, and Ribociclib Among Patients with HR+/HER2- Metastatic Breast CancerTimothy J Pluard, Rickard Sandin, Rohan C Parikh, et al.
Plos One|September 23, 2015
FXN Promoter Silencing in the Humanized Mouse Model of Friedreich AtaxiaYogesh K Chutake, Whitney N Costello, Christina C Lam, et al.
Future Oncology (London, England)|August 14, 2024
Treatment characteristics and outcomes in lower-risk, non-del(5q) myelodysplastic syndromes: findings from a medical record review in the USA, Canada and EuropeMaria Diez-Campelo, Aylin Yucel, Ravi K Goyal, et al.
European Journal of Gastroenterology & Hepatology|September 24, 2025
Disease burden, diagnosis pathways and treatment patterns in patients with eosinophilic esophagitis: a real-world studyChristopher Ma, Ulrike von Arm, Frank Zerbib, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 7, 2020
Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2- metastatic breast cancer in the United StatesRavi K Goyal, Gebra Cuyun Carter, Saurabh P Nagar, et al.
Cancer|April 15, 2025
Real-world treatment patterns and outcomes with oral azacitidine maintenance therapy in patients with acute myeloid leukemiaBrian Leber, Marcia T Ruiz, Hany Elgendy, et al.
Breast Cancer Research and Treatment|August 6, 2025
Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2- advanced breast cancer in EuropeOlga Oikonomidou, Mark J Beresford, Elena Galve-Calvo, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Genetic variation modulates susceptibility to aberrant DNA hypomethylation and imprint deregulation in naïve pluripotent stem cellsC Parikh, R A Glenn, Y Shi, et al.
Pageof 8